Navigation Links
Osseon Therapeutics Demonstrates to the European Medical Community How to 'Think Outside The Balloon' When Treating Vertebral Compression Fractures
Date:4/29/2010

LIVERPOOL, England, April 29 /PRNewswire/ -- At this week's BritSpine 2010 conference, Osseon Therapeutics is demonstrating to European surgeons and interventional radiologists how they can "think outside the balloon" when it comes to treating vertebral compression fractures brought on by osteoporosis, benign or malignant lesions and trauma.

The company's groundbreaking Osseoplasty 1.0 percutaneous vertebral augmentation system provides a safe, fast alternative for vertebral augmentation with cavity creation, and does so without  obstacles and device related complications and issues associated with other vertebral augmentation products.

"A recent study published in the January 2010 edition of the American Journal of Neuroradiology entitled Balloon-Related Complications and Technical Failures in Kyphoplasty for Vertebral Fractu
'/>"/>

SOURCE Osseon Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Osseon Launches in Europe
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Nov. 24, 2014  AiCure, an artificial intelligence ... to monitor medication ingestion, has announced the start ... intervene with patients receiving medication as maintenance therapy ... from prescription opiates have quadrupled in the last ... year than heroin, cocaine and benzodiazepines combined. Overall, ...
(Date:11/24/2014)... 2014  GlySens Incorporated announced today that it has ... the National Institute of Diabetes and Digestive and Kidney ... Health (NIH).  The grant is intended to support human ... term implantable glucose monitoring system.  Final preparations for launch ... to begin before the end of 2014. ...
(Date:11/24/2014)... CLEVELAND , 24 novembre 2014 /PRNewswire/ ... la sua tecnologia sarà esposta durante l,apertura ... di simulazione d,Europa, ossia la Fondazione IRCCS ... denominati SuRgical Planner (SRP) (strumento di pianificazione ... (piattaforma di navigazione chirurgica avanzata) saranno presentati ...
Breaking Medicine Technology:Can artificial intelligence solve the $55 billion problem of opioid abuse? 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 4
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, Jennifer E. Hill, ... from The American Association of Nurse Practitioners ... nurse practitioners. The Distinguished Preceptorship Award recognizes the ... significant contribution toward increasing the awareness and acceptance ... (AANP) is the largest full-service national professional membership ...
(Date:11/26/2014)... (HealthDay News) -- Vultures have developed highly specialized ways ... eating dead animals, researchers report. The new research ... faces and in the guts of 50 turkey vultures ... the faces of the vultures had more than 500 ... guts, the study found. The findings suggest that ...
(Date:11/26/2014)... to peanut protein in household dust may increase the ... condition eczema, a new study reveals. About 2 ... allergic to peanuts. And severe eczema in infants has ... researchers noted. The new study included 359 infants ... the amount of peanut protein the children were exposed ...
(Date:11/26/2014)... (HealthDay News) -- Parents need to take an active ... expert warns. Parents must make sure sports-playing teens ... David Dodick, chair of the American Migraine Foundation and ... of Medicine in Scottsdale, Ariz. in an American Migraine ... Any coach involved with teens sports needs to have ...
(Date:11/24/2014)... Los Angeles, CA (PRWEB) November 24, 2014 ... to bringing its readers reviews of affordable skin care ... , the casual blog offers readers a wide variety ... the market as well as organic skincare alternatives. , ... Healthy Skin Care Journal’s main content includes thoroughly researched ...
Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2
... most from chemo after surgery, study says , , FRIDAY, May ... help determine which patients with early-stage non-small cell lung cancer ... chemotherapy, a new study shows. , By extension, the ... forms of the cancer who would be able to forego ...
... and five year-old Chinese students learn the lesson of helping ... in the wake ... In the aftermath of the,devastating Sichuan earthquake, even the youngest ... donation and relief efforts. All around the,country, schools are running ...
... today the,hiring of John Mongeon as their new ... the Government Services Division for (ISC)2,Americas where he ... credential, one of the top security certifications in ... Florida, recently left (ISC)2,Americas to spend more time ...
... at least a year or two, , , FRIDAY, May ... with type 1 diabetes live insulin-free for at least ... improved metabolic control even after people have to begin ... monitoring systems, researchers from the University of Miami Miller ...
... McGraw-Hill Professional, a leading,global provider of information resources ... redesign of its flagship product,AccessMedicine. Featuring a customizable ... of the clinical and educational tools available on ... locate images, video, and audio., AccessMedicine is ...
... Board Member Educates FDA on Concerns that Improper Labeling of ... ... Screenings, ANNAPOLIS, Md., May 16 ... Quality Colorectal Cancer,Screening and Care ("Coalition"), a 501(c) 6 not-for-profit association,testified ...
Cached Medicine News:Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:Islet Cell Transplants Aid Type 1 Diabetics 2Health News:Islet Cell Transplants Aid Type 1 Diabetics 3Health News:McGraw-Hill Professional Redesigns AccessMedicine, Highlighting Media and Educational Features 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Testifies Before FDA Advisory Panel on Fospropofol Labeling: 2